Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/'Spice' constituent JWH-018 in mice

Behavioural Pharmacology

Volumn 25, Issue 3, 2014, Pages 253-257

  Hyatt, William S ^a   Fantegrossi, William E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

abuse liability; cannabinoid; conditioned place preference; conditioned taste aversion; mouse

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; CANNABINOID; DRONABINOL; 1-PENTYL-3-(1-NAPHTHOYL)INDOLE; INDOLE DERIVATIVE; NAPHTHALENE DERIVATIVE;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; CONDITIONED PLACE PREFERENCE TEST; DRUG EFFICACY; DRUG INHIBITION; DRUG MECHANISM; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; REWARD; TASTE AVERSION; ANIMAL; AVOIDANCE BEHAVIOR; DRUG EFFECTS; DRUG INTERACTION; INSTRUMENTAL CONDITIONING; REINFORCEMENT;

ANIMALS; APPETITE; AVOIDANCE LEARNING; CONDITIONING, OPERANT; DRONABINOL; DRUG INTERACTIONS; INDOLES; MALE; MICE; NAPHTHALENES; REINFORCEMENT SCHEDULE;

EID: 84899953226     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0000000000000034     Document Type: Article

References (25)

1. Adams IB, Martin BR (1996). Cannabis: pharmacology and toxicology in animalsand humans. Addiction 91:1585-1614.
2. Atwood BK, Huffman J, Straiker A, Mackie K (2010). JWH018, a commonconstituent of 'Spice' herbal blends, is a potent and efficacious cannabinoidCB receptor agonist. Br J Pharmacol 160:585-593.
3. Bardo MT, Bevins RA (2000). Conditioned place preference: what does it add toour preclinical understanding of drug reward? Psychopharmacology (Berl)153:31-43.
4. Brents LK, Reichard EE, Zimmerman SM, Moran JH, Fantegrossi WE, Prather PL(2011). Phase I hydroxylated metabolites of the K2 synthetic cannabinoidJWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity andactivity. PLoS One 6:c21917.
5. Brents LK, Zimmerman SM, Saffell AR, Prather PL, Fantegrossi WE (2013).Differential drug-drug interactions of the synthetic cannabinoids JWH-018and JWH-073: implications for drug abuse liability and pain therapy.J Pharmacol Exp Ther 346:350-361.
6. Castañé A, Robledo P, Matifas A, Kieffer BL, Maldonado R (2003). Cannabinoidwithdrawal syndrome is reduced in double mu and delta opioid receptorknockout mice. Eur J Neurosci 17:155-159.
7. Davis CM, Riley AL (2010). Conditioned taste aversion learning: implications foranimal models of drug abuse. Ann NY Acad Sci 1187:247-275.
8. Fantegrossi WE, Franks LN, Vasiljevik T, Prather PL (2013). Tolerance andcross-tolerance among high-efficacy synthetic cannabinoids JWH-018and JWH-073 and low-efficacy phytocannabinoid D9-THC. FASEB J27:1097.
9. Fischer GJ, Vail BJ (1980). Preexposure to delta-9-THC blocks THC-inducedconditioned taste aversion in rats. Behav Neural Biol 30:191-196.
10. Gunderson EW, Haughey HM, Ait-Daoud N, Joshi AS, Hart CL (2012). "Spice"and "K2" herbal highs: a case series and systematic review of the clinicaleffects and biopsychosocial implications of synthetic cannabinoid use inhumans. Am J Addict 21:320-326.
11. Hruba L, Ginsburg BC, McMahon LR (2012). Apparent inverse relationshipbetween cannabinoid agonist efficacy and tolerance/cross-tolerance producedby D9-tetrahydrocannabinol treatment in rhesus monkeys. J PharmacolExp Ther 342:843-849.
12. Hu X, Primack BA, Barnett TE, Cook RL (2011). College students and use of K2:an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy6:16.
13. Muller H, Huttner HB, Kohrmann M, Wielopolski JE, Kornhuber J, Sperling W(2010). Panic attack after Spice abuse in a patient with ADHD. Pharmacopsychiatry 43:152-153.
14. Nacca N, Vatti D, Sullivan R, Sud P, Su M, Marraffa J (2013). The syntheticcannabinoid withdrawal syndrome. J Addict Med 7:296-298.
15. Riley AL (2011). The paradox of drug taking: the role of the aversive effectsof drugs. Physiol Behav 103:69-78.
16. Robinson TE, Berridge KC (2008).The incentive sensitization theory ofaddiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363:3137-3146.
17. Schneir AB, Cullen J, Ly BT (2011). "Spice" girls: Synthetic cannabinoidintoxication. J Emerg Med 40:296-299.
18. Switzman L, Fishman B, Amit Z (1981). Pre-exposure effects of morphine,diazepam and delta 9-THC on the formation of conditioned taste aversions.Psychopharmacology (Berl) 74:149-157.
19. Tzschentke TM (2007). Measuring reward with the conditioned place preference(CPP) paradigm: update of the last decade. Addict Biol 12:227-462.
20. Valjent E, Maldonado R (2000). A behavioural model to reveal place preference todelta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147:436-438.
21. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R (2002). Behaviouraland biochemical evidence for interactions between delta 9-tetrahydrocannabinoland nicotine. Br J Pharmacol 135:564-578.
22. Vandrey R, Dunn KE, Fry JA, Girling ER (2012). A survey study to characterizeuse of Spice products (synthetic cannabinoids). Drug Alcohol Depend120:238-241.
23. Vardakou I, Pistos C, Spiliopoulou C (2010). Spice drugs as a new trend: modeof action, identification and legislation. Toxicol Lett 197:157-162.
24. Vearrier D, Osterhoudt KC (2010). A teenager with agitation: higher than sheshould have climbed. Pediatr Emerg Care 26:462-465.
25. Zimmermann US, Winkelmann PR, Pilhatsch M, Nees JA, Spanagel R, Schulz K(2009). Withdrawal phenomena and dependence syndrome after theconsumption of "Spice Gold". Dtsch Arztebl Int 106:464-467.